These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9737677)

  • 21. CD8high+ (CD57+) T cells in patients with rheumatoid arthritis.
    Wang EC; Lawson TM; Vedhara K; Moss PA; Lehner PJ; Borysiewicz LK
    Arthritis Rheum; 1997 Feb; 40(2):237-48. PubMed ID: 9041935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
    Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
    J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric analysis of TCR Vβ repertoire in patients with 22q11.2 deletion syndrome.
    McLean-Tooke A; Barge D; Spickett GP; Gennery AR
    Scand J Immunol; 2011 Jun; 73(6):577-85. PubMed ID: 21323691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly conserved TCR beta chain CDR3 sequences among immunodominant acetylcholine receptor-reactive T cells in murine myasthenia gravis.
    Pierce JL; Zborowski KA; Kraig E; Infante AJ
    Int Immunol; 1994 May; 6(5):775-83. PubMed ID: 8080845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients.
    Grunewald J; Hultman T; Bucht A; Eklund A; Wigzell H
    Mol Med; 1995 Mar; 1(3):287-96. PubMed ID: 8529107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded T cell clones and cytokines expression in human gastric carcinomas of different histological types.
    Zhang X; Chan WY; Liu Y; Chow JH; Fan D
    Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):120-3. PubMed ID: 12419157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the expanded T-cell populations in patients with Wegener's granulomatosis.
    Giscombe R; Wang XB; Kakoulidou M; Lefvert AK
    J Intern Med; 2006 Sep; 260(3):224-30. PubMed ID: 16918819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoreactive T cell responses and cytokine patterns reflect resistance to experimental autoimmune myasthenia gravis in Wistar Furth rats.
    Zhang GX; Ma CG; Xiao BG; van de Meide PH; Link H
    Eur J Immunol; 1996 Nov; 26(11):2552-8. PubMed ID: 8921938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells.
    Raitakari M; Brown RD; Sze D; Yuen E; Barrow L; Nelson M; Pope B; Esdale W; Gibson J; Joshua DE
    Br J Haematol; 2000 Jul; 110(1):203-9. PubMed ID: 10930999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell receptor Vbeta repertoire usage and clonal expansion of T cells in chronic myelogenous leukemia.
    Li YQ; Yang LJ; Chen SH; Zhang YP; Zhang XL; Luo GX
    Chin Med J (Engl); 2004 Jun; 117(6):840-3. PubMed ID: 15198883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the factors inducing the development of childhood-onset myasthenia gravis using CDR3 spectratyping analysis of the TCR repertoire.
    Dokai H; Nomura Y; Fujikawa Y; Nihei K; Segawa M; Shinomiya N
    J Neuroimmunol; 2007 Jul; 187(1-2):192-200. PubMed ID: 17560663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bakhiet M; van der Meide P; Wigzell H; Link H; Olsson T
    J Exp Med; 1996 Aug; 184(2):349-56. PubMed ID: 8760788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis.
    Li X; Xiao BG; Xi JY; Lu CZ; Lu JH
    Clin Immunol; 2008 Feb; 126(2):180-8. PubMed ID: 18054287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
    Yi Q; Lefvert AK
    J Immunol; 1994 Oct; 153(7):3353-9. PubMed ID: 8089503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylcholine receptor-specific CD4+ T cells in myasthenia gravis patients have individual, but restricted TCR V beta usage.
    Raju R; Navaneetham D; Protti MP; Horton RM; Hoppe BL; Howard J; Conti-Fine BM
    Ann N Y Acad Sci; 1998 May; 841():324-8. PubMed ID: 9668251
    [No Abstract]   [Full Text] [Related]  

  • 37. T-cell receptor Vβ repertoire analysis in patients with chronic idiopathic neutropenia demonstrates the presence of aberrant T-cell expansions.
    Spanoudakis M; Koutala H; Ximeri M; Pyrovolaki K; Stamatopoulos K; Papadaki HA
    Clin Immunol; 2010 Dec; 137(3):384-95. PubMed ID: 20864416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental autoimmune myasthenia gravis in B10.BV8S2 transgenic mice: preferential usage of TCRAV1 gene by lymphocytes responding to acetylcholine receptor.
    Kaul R; Wu B; Goluszko E; Deng C; Dedhia V; Nabozny GH; David CS; Rimm IJ; Shenoy M; Haqqi TM; Christadoss P
    J Immunol; 1997 Jun; 158(12):6006-12. PubMed ID: 9190955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.